Publications Board Minutes Agendas Newsletters Guidance Documents Reports News Releases Board Actions Guidance Documents Compounding Notice on the Enforcement of USP Compounding Chapters for PharmaciesTerminal Distributor Requirements for Prescribers Possessing Compounded Drugs or Engaging in Drug CompoundingHazardous Drug Compounding by PrescribersLicensure as an Outsourcing FacilityClarification on Allergen ExtractsCompounding for Drug ShortagesOhio Licensed Outsourcing FacilitiesCompounding in Ohio Consult Agreements Pharmacist Consult Agreement with Physicians Controlled Substances Statement on the Descheduling of EpidiolexControlled Substance Inventory RequirementsRequirements for Outpatient Opioid PrescriptionsPrescibing Opioids to MinorsFor Prescribers - New Limits on Prescription Opioids for Acute PainFor Pharmacists - New Limits on Prescription Opioids for Acute PainClarification on Transfer of Unfilled Controlled Substance Prescriptions Coronavirus (COVID-19) Resources Annual Controlled Substance Inventory RequirementsAuthorization for Nurses to Stock Automated Drug Storage SystemsAuthorization for Pharmacists, Pharmacy Interns, and Pharmacy Technicians Licensed in Other States to Work in OhioBorder State Shipment Request FormCOVID-19 Checklist for PharmaciesCOVID-19 Drug Shortage GuidanceCOVID-19 Response EffortsDEA Guidance on Oral Schedule II Controlled Substance PrescriptionsDelay of Drug Distributor Customer Due Diligence RequirementsDelivery by Opioid Treatment ProgramsDrug Compounding Resolutions and Guidance During COVID-19Emergency Rule for Dispensing Chloroquine and HydroxychloroquineExpansion of Pharmacist Pharmacy Intern and Certified Pharmacy Technician Testing Authority During COVID-19Expedited Licensure of Drug DistributorsExpedited Onboarding of Pharmacy Technician TraineesExtension of Emergency RefillsExtension of Registered Pharmacy Technician Renewal and Technician Trainee ExtensionsFDA Temporary Policy for Outsourcing FacilitiesNurses Personally Furnishing Non-Controlled DrugsOut-of-State Pharmacy Personnel Notification FormOut-of-State Shipment Notification FormPersonally Furnishing Buprenorphine Products by Opioid Treatment ProgramsReinstatement of Lapsed or Expired Ohio Pharmacist Licenses During COVID-19Remote Processing Guidance in Response to COVID-19Repackaging or Combining Propofol Drug Products During the COVID-19 Public Health EmergencyResponsible RestartOhio Guidance for LicenseesResponsible RestartOhio Requirements for LicenseesSale and Shipment of Non-Reportable Dangerous Drugs from Unlicensed Out-of-State FacilitiesSale and Shipment of Non-Reportable Patient-Specific Medications by Non-Ohio Licensed Border State FacilitiesTechnician Trainee Supervision Waiver Request FormTemporary Expansion of Registered Pharmacy Technician Duties and Clarification on Certified Technician Prescription TransfersTemporary Expansion of the Maximum Days Supply for Multiple Drugs in Single-Dose ContainersTemporary Extension of Basic Life Support Requirements for Pharmacists and Pharmacy InternsTemporary Ohio Pharmacist License Reinstatement ApplicationTerminal Distributor Satellite Registration FormUse of Certified Nurse Practitioners, Clinical Nurse Specialists, Certified Nurse Midwives, and Physician Assistants in the Management of Pharmacist Consult AgreementsUse of Temporary Satellite Locations for the Storage and Use of Dangerous Drugs During COVID-19Waiver of the 5 Percent Limit on Occasional Wholesale SalesWaivers for Pharmacy Technician Trainee Supervision Dangerous Drugs Temporary Authorization to Move Dangerous Drugs in the Event of an EmergencyDispensing Prescriptions by Prescribers Experiencing a Change of StatusDispensing of Emergency Supply of Medication without a PrescriptionLicensure Requirements for Boards of Health During Emergency Preparedness Incidents or Public Health EmergenciesPoint of Dispensing Locations in a Declared Public Health EmergencyPharmacy Laws on Epinephrine AutoinjectorsProcurement of Epinephrine Autoinjectors by Schools and CampsAddressing Possible Shortages of Oseltamivir Products Used to Treat InfluenzaAdministration of Injections by PharmacistsDispensing Multiple Simultaneous Refills of PrescriptionsExpedited Partner Therapy (EPT)Delivery of Non-Self Injectable DrugsDispensing Naltrexone without a PrescriptionIssuing a Valid Prescription - What Every Prescriber Needs to Know Drug Repository Programs Operating a Drug Repository Program Drug Disposal Drug Disposal Resources Drug Enforcement Administration Rules on Pharmaceutical Drug Collection Electronic Prescribing Clarification on Mandatory E-PrescribingApproval of Electronic Prescription Transmission Systems & Computerized Prescriber Order Entry SystemsPrinting of Electronic Prescriptions Emergency Medical Services Emergency Medical Services - Frequently Asked Questions Immunizations Approved Immunization CoursesPharmacist Use of the Ohio Impact Statewide Immunization Information SystemImmunizations by Pharmacists and Pharmacy Interns Key Boxes Use of Key Boxes by First Responders to Obtain Access to a Pharmacy Medical Marijuana Control Program Participation in the Ohio Medical Marijuana Control ProgramGuidance on Products Derived from Hemp Naloxone Naloxone Resources Ohio Automated Rx Reporting System OARRS Rules & Corresponding Responsibility OARRS Fact Sheet for PharmacistsReporting Naltrexone Products to OARRS - Effective 3.19.2019DEA Plus Suffix Upload InstructionsMandatory OARRS Registration and Requests Positive Identification Positive Identification And Hospital Electronic Drug Record Keeping Systems Protocols Influenza Outbreak Management in Long-Term Care Facilities by Emergency ProtocolJoint Regulatory Statement - Use of Protocols to Initiate or Adjust Medications Suspicious Order Monitoring Suspicious Order Monitoring and Due Diligence Theft or Loss Reporting Reporting Theft or Loss of Dangerous Drugs and Drug DocumentsSubmitting Theft or Loss Reports